Our studies collectively identify a novel mechanism promoting PDK1 protein expression and further advance our knowledge of the molecular mechanism underlying the tumor-promoting activity of MAPK4, an emerging novel therapeutic target for human cancers. Here, MAPK4 is linked to neoplasm.